Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 3/2007

01-03-2007 | Original Paper

Human xenograft osteosarcoma models with spontaneous metastasis in mice: clinical relevance and applicability for drug testing

Authors: Crispin R. Dass, Eugene T. H. Ek, Peter F. M. Choong

Published in: Journal of Cancer Research and Clinical Oncology | Issue 3/2007

Login to get access

Abstract

Osteosarcoma cells derived from patients have been isolated and subsequently cultured for the past 35 years. To date though, there have been no major break-throughs in the development of a model for osteosarcoma that uses orthotopic implantation of human osteosarcoma cells and that closely emulates the clinical progression of this debilitating and fatal disease. Such a model is long overdue given the devastating demographics (second highest cause of cancer-related death in the paediatric age group) of the ailment and the lack of solid options for control, if not cure, for the disease, as it also is the most common primary tumour of bone. Only then can more robust R & D be undertaken in the search for efficacious anti-osteosarcoma agents. This review tackles this conundrum and lists the variety of models (that use human osteosarcoma cells) available and the types of studies performed with these.
Literature
go back to reference Arnstein P, Taylor DO, Nelson-Rees WA, Huebner RJ, Lennette EH (1974) Propagation of human tumors in antithymocyte serum-treated mice. J Natl Cancer Inst 52(1):71–84PubMed Arnstein P, Taylor DO, Nelson-Rees WA, Huebner RJ, Lennette EH (1974) Propagation of human tumors in antithymocyte serum-treated mice. J Natl Cancer Inst 52(1):71–84PubMed
go back to reference Berlin O, Samid D, Donthineni-Rao, Akeson W, Amiel D, Woods V (1993) Development of a novel spontaneous metastasis model of human osteosarcoma transplanted orthotopically into the bone of athymic mice. Cancer Res 53:4890–4895PubMed Berlin O, Samid D, Donthineni-Rao, Akeson W, Amiel D, Woods V (1993) Development of a novel spontaneous metastasis model of human osteosarcoma transplanted orthotopically into the bone of athymic mice. Cancer Res 53:4890–4895PubMed
go back to reference de Bock CE, Lin Z, Itoh T, Morris D, Murrell G, Wang Y (2005) Inhibition of urokinase receptor gene expression and cell invasion by anti-uPAR DNAzymes in osteosarcoma cells. FEBS J 272(14):3572–3582PubMedCrossRef de Bock CE, Lin Z, Itoh T, Morris D, Murrell G, Wang Y (2005) Inhibition of urokinase receptor gene expression and cell invasion by anti-uPAR DNAzymes in osteosarcoma cells. FEBS J 272(14):3572–3582PubMedCrossRef
go back to reference Dass CR, Nadesapillai AW, Fisher JL, Howard M, Zhou H, Choong PFM (2006) Downregulation of uPAR confirms link in osteosarcoma. Clin Exp Metastasis 23 (in press) Dass CR, Nadesapillai AW, Fisher JL, Howard M, Zhou H, Choong PFM (2006) Downregulation of uPAR confirms link in osteosarcoma. Clin Exp Metastasis 23 (in press)
go back to reference Chen DS, Zhu NL, Hung G, Skotzko MJ, Hinton DR, Tolo V, Hall FL, Anderson WF, Gordon EM (1997) Retroviral vector-mediated transfer of an antisense cyclin G1 construct inhibits osteosarcoma tumor growth in nude mice. Hum Gene Ther 8(14):1667–1674PubMed Chen DS, Zhu NL, Hung G, Skotzko MJ, Hinton DR, Tolo V, Hall FL, Anderson WF, Gordon EM (1997) Retroviral vector-mediated transfer of an antisense cyclin G1 construct inhibits osteosarcoma tumor growth in nude mice. Hum Gene Ther 8(14):1667–1674PubMed
go back to reference Chen X, Li Y, Xiong K, Aizicovici S, Xie Y, Zhu Q, Sturtz F, Shulok J, Snodgrass R, Wagner TE, Platika D (1998) Cancer gene therapy by direct tumor injections of a nonviral T7 vector encoding a thymidine kinase gene. Hum Gene Ther 9(5):729–736PubMed Chen X, Li Y, Xiong K, Aizicovici S, Xie Y, Zhu Q, Sturtz F, Shulok J, Snodgrass R, Wagner TE, Platika D (1998) Cancer gene therapy by direct tumor injections of a nonviral T7 vector encoding a thymidine kinase gene. Hum Gene Ther 9(5):729–736PubMed
go back to reference Clapham P, Nagy K, Cheingsong-Popov R, Exley M, Weiss RA (1983) Productive infection and cell-free transmission of human T-cell leukemia virus in a nonlymphoid cell line. Science 222(4628):1125–1127PubMedCrossRef Clapham P, Nagy K, Cheingsong-Popov R, Exley M, Weiss RA (1983) Productive infection and cell-free transmission of human T-cell leukemia virus in a nonlymphoid cell line. Science 222(4628):1125–1127PubMedCrossRef
go back to reference Fisher JL, Mackie PS, Howard ML, Zhou H, Choong PF (2001) The expression of urokinase plasminogen activator system in metastatic murine osteosarcoma: an in vivo mouse model. Clin Cancer Res 1654(7):1654–1660 Fisher JL, Mackie PS, Howard ML, Zhou H, Choong PF (2001) The expression of urokinase plasminogen activator system in metastatic murine osteosarcoma: an in vivo mouse model. Clin Cancer Res 1654(7):1654–1660
go back to reference Fogh J, Fogh JM, Orfeo T (1977) One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 59(1):221–226PubMed Fogh J, Fogh JM, Orfeo T (1977) One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 59(1):221–226PubMed
go back to reference Friedlaender GE, Mitchell MS (1976) A virally induced osteosarcoma in rats. A model for immunological studies of human osteosarcoma. J Bone Joint Surg Am 58(3):295–302PubMed Friedlaender GE, Mitchell MS (1976) A virally induced osteosarcoma in rats. A model for immunological studies of human osteosarcoma. J Bone Joint Surg Am 58(3):295–302PubMed
go back to reference Ho WZ, Harouse JM, Rando RF, Gonczol E, Srinivasan A, Plotkin SA (1990) Reciprocal enhancement of gene expression and viral replication between human cytomegalovirus and human immunodeficiency virus type 1. J Gen Virol 71(Pt 1):97–103PubMedCrossRef Ho WZ, Harouse JM, Rando RF, Gonczol E, Srinivasan A, Plotkin SA (1990) Reciprocal enhancement of gene expression and viral replication between human cytomegalovirus and human immunodeficiency virus type 1. J Gen Virol 71(Pt 1):97–103PubMedCrossRef
go back to reference Jia SF, Worth LL, Kleinerman ES (1999) A nude mouse model of human osteosarcoma lung metastases for evaluating new therapeutic strategies. Clin Exp Metastasis 17(6):501–506PubMedCrossRef Jia SF, Worth LL, Kleinerman ES (1999) A nude mouse model of human osteosarcoma lung metastases for evaluating new therapeutic strategies. Clin Exp Metastasis 17(6):501–506PubMedCrossRef
go back to reference Jia SF, Worth LL, Turan M, Duan Xp XP, Kleinerman ES (2002) Eradication of osteosarcoma lung metastasis using intranasal gemcitabine. Anticancer Drugs 13(2):155–161PubMedCrossRef Jia SF, Worth LL, Turan M, Duan Xp XP, Kleinerman ES (2002) Eradication of osteosarcoma lung metastasis using intranasal gemcitabine. Anticancer Drugs 13(2):155–161PubMedCrossRef
go back to reference Khanna C, Prehn J, Yeung C, Caylor J, Tsokos M, Helman L (2000) An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential. Clin Exp Metastasis 18(3):261–271PubMedCrossRef Khanna C, Prehn J, Yeung C, Caylor J, Tsokos M, Helman L (2000) An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential. Clin Exp Metastasis 18(3):261–271PubMedCrossRef
go back to reference Kim EM, Sivanandham M, Stavropoulos CI, Wallack MK (2002) Adjuvant effect of a Flt3 ligand (FL) gene-transduced xenogeneic cell line in a murine colon cancer model. J Surg Res 108(1):148–156PubMedCrossRef Kim EM, Sivanandham M, Stavropoulos CI, Wallack MK (2002) Adjuvant effect of a Flt3 ligand (FL) gene-transduced xenogeneic cell line in a murine colon cancer model. J Surg Res 108(1):148–156PubMedCrossRef
go back to reference Lind M, Eriksen EF, Bunger C (1996) Bone morphogenetic protein-2 but not bone morphogenetic protein-4 and -6 stimulates chemotactic migration of human osteoblasts, human marrow osteoblasts, and U2-OS cells. Bone 18(1):53–57PubMedCrossRef Lind M, Eriksen EF, Bunger C (1996) Bone morphogenetic protein-2 but not bone morphogenetic protein-4 and -6 stimulates chemotactic migration of human osteoblasts, human marrow osteoblasts, and U2-OS cells. Bone 18(1):53–57PubMedCrossRef
go back to reference Link MP, Goorin AM, Miser AW et al (1986) The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 314(25):1600–1606PubMedCrossRef Link MP, Goorin AM, Miser AW et al (1986) The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 314(25):1600–1606PubMedCrossRef
go back to reference Luu HH, Kang Q, Park JK, Si W, Luo Q, Jiang W, Yin H, Montag AG, Simon MA, Peabody TD, Haydon RC, Rinker-Schaeffer CW, He TC (2005) An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis. Clin Exp Metastasis 22(4):319–329PubMedCrossRef Luu HH, Kang Q, Park JK, Si W, Luo Q, Jiang W, Yin H, Montag AG, Simon MA, Peabody TD, Haydon RC, Rinker-Schaeffer CW, He TC (2005) An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis. Clin Exp Metastasis 22(4):319–329PubMedCrossRef
go back to reference Manara MC, Baldini N, Serra M, Lollini PL, De Giovanni C, Vaccari M, Argnani A, Benini S, Maurici D, Picci P, Scotlandi K (2000) Reversal of malignant phenotype in human osteosarcoma cells transduced with the alkaline phosphatase gene. Bone 26(3):215–220PubMedCrossRef Manara MC, Baldini N, Serra M, Lollini PL, De Giovanni C, Vaccari M, Argnani A, Benini S, Maurici D, Picci P, Scotlandi K (2000) Reversal of malignant phenotype in human osteosarcoma cells transduced with the alkaline phosphatase gene. Bone 26(3):215–220PubMedCrossRef
go back to reference Mankin HJ, Hornicek FJ, Rosenberg AE et al (2004) Survival data for 648 patients with osteosarcoma treated at one institution. Clin Orthop 429:286–291PubMedCrossRef Mankin HJ, Hornicek FJ, Rosenberg AE et al (2004) Survival data for 648 patients with osteosarcoma treated at one institution. Clin Orthop 429:286–291PubMedCrossRef
go back to reference McAllister RM, Gardner MB, Greene AE, Bradt C, Nichols WW, Landing BH (1971) Cultivation in vitro of cells from a human osteosarcoma. Cancer 27:397–402PubMedCrossRef McAllister RM, Gardner MB, Greene AE, Bradt C, Nichols WW, Landing BH (1971) Cultivation in vitro of cells from a human osteosarcoma. Cancer 27:397–402PubMedCrossRef
go back to reference McAllister RM, Nelson-Rees WA, Peer M, Laug WE, Isaacs H Jr, Gilden RV, Rongey RW, Gardner MB (1975) Childhood sarcomas and lymphomas. Characterization of new cell lines and search for type-C virus. Cancer 36(5):1804–1814PubMedCrossRef McAllister RM, Nelson-Rees WA, Peer M, Laug WE, Isaacs H Jr, Gilden RV, Rongey RW, Gardner MB (1975) Childhood sarcomas and lymphomas. Characterization of new cell lines and search for type-C virus. Cancer 36(5):1804–1814PubMedCrossRef
go back to reference McGary EC, Weber K, Mills L, Doucet M, Lewis V, Lev DC, Fidler IJ, Bar-Eli M (2002) Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571. Clin Cancer Res 8(11):3584–3591PubMed McGary EC, Weber K, Mills L, Doucet M, Lewis V, Lev DC, Fidler IJ, Bar-Eli M (2002) Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571. Clin Cancer Res 8(11):3584–3591PubMed
go back to reference McGary EC, Heimberger A, Mills L, Weber K, Thomas GW, Shtivelband M, Lev DC, Bar-Eli M (2003) A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo. Clin Cancer Res 9(17):6560–6566PubMed McGary EC, Heimberger A, Mills L, Weber K, Thomas GW, Shtivelband M, Lev DC, Bar-Eli M (2003) A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo. Clin Cancer Res 9(17):6560–6566PubMed
go back to reference Mirandola P, Sponzilli I, Gobbi G, Marmiroli S, Rinaldi L, Binazzi R, Piccari GG, Ramazzotti G, Gaboardi GC, Cocco L, Vitale M (2006) Anticancer agents sensitize osteosarcoma cells to TNF-related apoptosis-inducing ligand downmodulating IAP family proteins. Int J Oncol 28(1):127–133PubMed Mirandola P, Sponzilli I, Gobbi G, Marmiroli S, Rinaldi L, Binazzi R, Piccari GG, Ramazzotti G, Gaboardi GC, Cocco L, Vitale M (2006) Anticancer agents sensitize osteosarcoma cells to TNF-related apoptosis-inducing ligand downmodulating IAP family proteins. Int J Oncol 28(1):127–133PubMed
go back to reference Morin KW, Duan W, Knaus EE, McEwan AJ, Wiebe LI (2005) A human osteosarcoma cell line expressing herpes simplex type-1 thymidine kinase: studies with radiolabeled (E)-5-(2-iodovinyl)-2′-fluoro-2′-deoxyuridine. Nucl Med Biol 32(5):459–464PubMedCrossRef Morin KW, Duan W, Knaus EE, McEwan AJ, Wiebe LI (2005) A human osteosarcoma cell line expressing herpes simplex type-1 thymidine kinase: studies with radiolabeled (E)-5-(2-iodovinyl)-2′-fluoro-2′-deoxyuridine. Nucl Med Biol 32(5):459–464PubMedCrossRef
go back to reference Navaraj A, Mori T, El-Deiry WS (2005) Cooperation between BRCA1 and p53 in repair of cyclobutane pyrimidine dimers. Cancer Biol Ther 4(12):1409–1414PubMedCrossRef Navaraj A, Mori T, El-Deiry WS (2005) Cooperation between BRCA1 and p53 in repair of cyclobutane pyrimidine dimers. Cancer Biol Ther 4(12):1409–1414PubMedCrossRef
go back to reference Orimo H, Shimada T (2005) Regulation of the human tissue-nonspecific alkaline phosphatase gene expression by all-trans-retinoic acid in SaOS-2 osteosarcoma cell line. Bone 36(5):866–876PubMedCrossRef Orimo H, Shimada T (2005) Regulation of the human tissue-nonspecific alkaline phosphatase gene expression by all-trans-retinoic acid in SaOS-2 osteosarcoma cell line. Bone 36(5):866–876PubMedCrossRef
go back to reference Ponten J, Saksela E (1967) Two established in vitro cell lines from human mesenchymal tumours. Int J Cancer 2:434–447PubMed Ponten J, Saksela E (1967) Two established in vitro cell lines from human mesenchymal tumours. Int J Cancer 2:434–447PubMed
go back to reference Rhim JS, Cho HY, Vernon ML, Arnstein P, Huebner RJ, Gilden RV (1975) Characterization of non-producer human cells induced by Kirsten sarcoma virus. Int J Cancer 16(5):840–849PubMed Rhim JS, Cho HY, Vernon ML, Arnstein P, Huebner RJ, Gilden RV (1975) Characterization of non-producer human cells induced by Kirsten sarcoma virus. Int J Cancer 16(5):840–849PubMed
go back to reference Schmidt J, Strauss GP, Schon A, Luz A, Murray AB, Melchiori A, Aresu O, Erfle V (1988) Establishment and characterisation of osteogenic cell lines from a spontaneous murine osteosarcoma. Differentiation 39(3):151–160PubMedCrossRef Schmidt J, Strauss GP, Schon A, Luz A, Murray AB, Melchiori A, Aresu O, Erfle V (1988) Establishment and characterisation of osteogenic cell lines from a spontaneous murine osteosarcoma. Differentiation 39(3):151–160PubMedCrossRef
go back to reference Sihn CR, Suh EJ, Lee KH, Kim SH (2005) Sec13 induces genomic instability in U2OS cells. Exp Mol Med 37(3):255–260PubMed Sihn CR, Suh EJ, Lee KH, Kim SH (2005) Sec13 induces genomic instability in U2OS cells. Exp Mol Med 37(3):255–260PubMed
go back to reference Stiller CA, Craft AW, Corazziari I (2001) Survival of children with bone sarcoma in Europe since 1978: results from the EUROCARE study. Eur J Cancer 37:760–766PubMedCrossRef Stiller CA, Craft AW, Corazziari I (2001) Survival of children with bone sarcoma in Europe since 1978: results from the EUROCARE study. Eur J Cancer 37:760–766PubMedCrossRef
go back to reference Worth LL, Jia SF, Zhou Z, Chen L, Kleinerman ES (2000) Intranasal therapy with an adenoviral vector containing the murine interleukin-12 gene eradicates osteosarcoma lung metastases. Clin Cancer Res 6(9):3713–3718PubMed Worth LL, Jia SF, Zhou Z, Chen L, Kleinerman ES (2000) Intranasal therapy with an adenoviral vector containing the murine interleukin-12 gene eradicates osteosarcoma lung metastases. Clin Cancer Res 6(9):3713–3718PubMed
go back to reference Yu Y, Harris RI, Yang JL, Anderson HC, Walsh WR (2004) Differential expression of osteogenic factors associated with osteoinductivity of human osteosarcoma cell lines. J Biomed Mater Res A 70(1):122–128PubMedCrossRef Yu Y, Harris RI, Yang JL, Anderson HC, Walsh WR (2004) Differential expression of osteogenic factors associated with osteoinductivity of human osteosarcoma cell lines. J Biomed Mater Res A 70(1):122–128PubMedCrossRef
go back to reference Zhou H, Choong PF, McCarthy R, Chou ST, Martin TK, Ng KW (1994) In situ hybridisation to show sequential expression of osteoblast gene markers during bone formation in vivo. J Bone Miner Res 9(9):1489–1499PubMedCrossRef Zhou H, Choong PF, McCarthy R, Chou ST, Martin TK, Ng KW (1994) In situ hybridisation to show sequential expression of osteoblast gene markers during bone formation in vivo. J Bone Miner Res 9(9):1489–1499PubMedCrossRef
go back to reference Zhu JJ, Li FB, Zhou JM, Liu ZC, Zhu XF, Liao WM (2005) The tumor suppressor p33ING1b enhances taxol-induced apoptosis by p53-dependent pathway in human osteosarcoma U2OS cells. Cancer Biol Ther 4(1):39–47PubMedCrossRef Zhu JJ, Li FB, Zhou JM, Liu ZC, Zhu XF, Liao WM (2005) The tumor suppressor p33ING1b enhances taxol-induced apoptosis by p53-dependent pathway in human osteosarcoma U2OS cells. Cancer Biol Ther 4(1):39–47PubMedCrossRef
go back to reference Zhu JJ, Li FB, Zhu XF, Liao WM (2006) The p33(ING1b) tumor suppressor cooperates with p53 to induce apoptosis in response to etoposide in human osteosarcoma cells. Life Sci 78(13):1469–1477PubMedCrossRef Zhu JJ, Li FB, Zhu XF, Liao WM (2006) The p33(ING1b) tumor suppressor cooperates with p53 to induce apoptosis in response to etoposide in human osteosarcoma cells. Life Sci 78(13):1469–1477PubMedCrossRef
Metadata
Title
Human xenograft osteosarcoma models with spontaneous metastasis in mice: clinical relevance and applicability for drug testing
Authors
Crispin R. Dass
Eugene T. H. Ek
Peter F. M. Choong
Publication date
01-03-2007
Publisher
Springer-Verlag
Published in
Journal of Cancer Research and Clinical Oncology / Issue 3/2007
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-006-0157-x

Other articles of this Issue 3/2007

Journal of Cancer Research and Clinical Oncology 3/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.